Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional
Official Title: A Phase II Study of Mocetinostat Administered With Gemcitabine for Patients With Metastatic Leiomyosarcoma With Progression or Relapse Following Prior Treatment With Gemci
Brief Summary: The purpose of this study is to assess the response rate (per RECIST 1.1) in participants who receive mocetinostat and gemcitabine after documented progression of leiomyosarcoma on a gemcitabine containing regimen.